Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Centessa Pharmaceuticals PLC Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $83.4 Billion
- Q1 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 257,418 shares of CNTA stock, worth $3.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
257,418
Previous 303,479
15.18%
Holding current value
$3.38 Million
Previous $5.08 Million
27.19%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
142Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$262 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$131 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$127 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$91.3 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$77.8 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.24B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...